TILT Biotherapeutics raises $10M to push ahead on cancer immunotherapies
TILT Biotherapeutics (TILT), a clinical-stage Finnish biotech company developing cancer immunotherapies, has completed the first…
15/06/2022 - 2 minutes
TILT Biotherapeutics (TILT), a clinical-stage Finnish biotech company developing cancer immunotherapies, has completed the first…